分享
分销 收藏 举报 申诉 / 79
播放页_导航下方通栏广告

类型14高反应性鼻炎医学PPT课件.ppt

  • 上传人:w****g
  • 文档编号:2566067
  • 上传时间:2024-06-01
  • 格式:PPT
  • 页数:79
  • 大小:6.49MB
  • 下载积分:16 金币
  • 播放页_非在线预览资源立即下载上方广告
    配套讲稿:

    如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。

    特殊限制:

    部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。

    关 键  词:
    14 反应 鼻炎 医学 PPT 课件
    资源描述:
    耳鼻咽喉头颈外科学耳鼻咽喉头颈外科学 耳鼻咽耳鼻咽喉头颈外科学喉头颈外科学第二篇第二篇 鼻科学及颅面疾病鼻科学及颅面疾病(3)第十一章第十一章鼻黏膜高反应性鼻病鼻黏膜高反应性鼻病第一节第一节变态反应变态反应性鼻炎性鼻炎Respiratory mucosa in noseThe nasal mucosa showed by transmi-ssional electromi-Croscope.The picture of normal mucosa showed by nasal endoscope Nasal hyper-reactivitynNasal cavity:nFirst line of airwaynSensitivity:nrich nerve distributionnMucosal compound:nrespiratory epithelial cells Goblet cell glands(serous or mucous)rich vessels nImmune compound:nToll-like receptors lymphocytes(T,B)serous cells mast cells epithelial cells Response of nose induced by some factorsChallenge factors:enviromentalWeather、temperature、humidityinhalants:Dust、allergen、chemicals pollution most of aboveIntrinsic:nervous、stress or disappoint、depress or anxious Nasal responseProtective Congestion reduce patency of the airway and amount of harmful gas and particles to enter airwayRhinorrheaTo discharge foreign particles and inflammatory mediators Sneeze rapidly rule out harmful gas and particles hyper-reactivity of Nasal mucosaThe difference of nasal mucosal reaction between physiologic and pathologic condition physiologic pathologic Inducer nervous stress immunologic (allergy)temperature change suddenly psychologic odor dust endocrine duration 4 days (consecutively)1hpathologic nerve reflex inflammation base (mainly)(mainly)高反应性鼻病高反应性鼻病Definition:Hyperreactive Rhinopathy is symptomic disorder and the reaction of nasal mucosa induced by stimuli exceed normal limitMain including:Allergic RhinitisNon-allergic rhinitiscold air inducing rhinitisendocrine rhinitisdrug inducing rhinitisnonallergic allergic rhinitis with eosinophiliavasomotor rhinitis(idiopathic rhinitis)Allergic rhinitisAllergic rhinitis is a symptomatic disorder of the nose induced after allergen exposure by an immunoglobulin E(IgE)-mediated inflammation of the membranes lining the noseDifinition of Allergic rhinitisKey point of the difinitionSusceptible individualInduced by allergen exposureIgE mediated mainlyNasal mucosa infalmmationMain symptoms include sneeze,rhinorrhea and obstruction allergenPollen:tree,grass,crop plant fugidust mitepet danderMechanism of allergic inflammation-Th2 responseTh2BIL-4变应原变应原Naive ThIgEIL-4IL-5释放释放 炎症介质炎症介质 毒性蛋白毒性蛋白 细胞因子细胞因子释放炎症介质释放炎症介质和细胞因子和细胞因子Eo变应性鼻炎免疫学机制变应性鼻炎免疫学机制以以Th2反应为主的免疫性疾病反应为主的免疫性疾病嗜酸性粒细胞嗜酸性粒细胞肥大细胞和肥大细胞和嗜碱性粒细胞嗜碱性粒细胞速发反应速发反应(Early PhaseReaction)迟发反应迟发反应(Late PhaseReaction)抗原提呈细胞抗原提呈细胞SymptomsNasal obstructionSymptoms1hr daylyLasting4ds weeklysneezeNose runningPale-edema mucosaNose itchHow are the symptoms caused?Irritation of freenerve endings-Itching and sneezingIncreasedmucus production -RhinorrhoeaVasodilation-Mucosa congestionIncreasedvascular permeability-Mucosa oedemaRelationship between up and low airwayMorbidity of asthma in Patients with allergic rhinitis is 3 times more than one who no allergic rhinitis20%of children with allergic rhinitis will occur asthma in life lateRelationship between up and low airwayMucosal inflammation is present in the entire airway of patients with allergic rhinitis and/or asthma.Upper airway inflammation is associated with bronchial hyperresponsivenessLower airway remodeling is present in asthmatic,but also in allergic rhinitis patients.Relationship between up and low airwayAllergic rhinitis and asthma are characterized by an inflammatory process that is marked histologically by tissue eosinophils,mast cells,T lymphocytes,macrophages,and epithelial cells.inflammationImportant ConceptOne airway,One diseaseGrowsman-1997Worldwide prevalence Prevalence of Allergic rhinitis in CHINA(2007)Increasing prevalence of ARThe cause may be associated with factors as follows:Air pollution:exhaust particle;ozone,NO2(nitrogen dioxide),SO2(sulfur dioxide)Life style:unsaturated acidHyper-HygieneThe impact of AR on quality of Live Quality of live(QOL):Sleepingworkstudyentertainmentsocial communication systemic fellingAllergic rhinitis and Its impact on asthma(2008)the WHO Guideline:Allergic rhinitis is a global health problem that causes major illness and disability worldwide.It affects social life,sleep,school and work.Both allergic rhinitis and asthma are systemic inflammatory conditions and are often co-morbidities.The economic impact of allergic rhinitis is substantial.Intermittent 4 days per weekor 3mm diameter reaction indicates that the patient is producing IgE antibodies to a specific allergen,and taken in conjunction with a positive history,is evidence that the allergen is responsible for the patients symptoms.Explanation of SPT result PositiveNotable:may see nearly 25%in normal Emphasizing:corresponding with history information:Yes make diagnosisNo may predictive Negative exclude drug effectunknow allergen may present non allergic Serum Specific IgE(sIgE)Specific IgE immunoassays may be used:extensive skin disease,skin test suppressive therapy(antihistamines)that cannot be discontinued,uncooperative patients,or when the history suggests an unusually high risk of anaphylaxis from skin testing.Positive results of testing specific IgE must be correlated with history and physical findings to assess their clinical SignificanceGenerally,sensitivety and specificity of SPT is superior to testing of serum specific IgE Differential diagnosisBy exclusive process(SPT;serum sIgE)Non-allergic nasal hyperreacive rhinitisVasomotor rhinitis(idiopathic)Non-allergic eosinophilia rhinitis(aspirin intolerance?)Hyper-reflective rhinitis(P substance?)Endocrine rhinitis(estrogn)Management of ARAllergen AvoidancePharmacotherapyImmunotherapyPharmacotherapyMedications used to treat allergic rhinits:nAntihistaminesnDecongestantsnCorticosteroidsnMast Cell stabilizersnAnticholinergicsnAntileukotrienes(抗白三(抗白三烯药烯药)Anti-HistaminesAct by preventing histamine from binding to the H1-receptorsPrimarily helpful in controlling Sneezing,itching&rhinorrhoea;ineffective in releiving nasal blockage1st generation anti-histamines-chlorpheniramine-diphenylhydramine2nd generation anti-histamines-cetrizine-azelastine-fexofenadine-loratadineAnti-HistaminesIndications:mild intermittent or persistent rhinitismoderate-severecombined with intranasal corticosteroids Generally,Second generation antihistamines is first choice advantage:long term effect no sedativeRoutes of administration oral or intranasalIntranasal corticosteroid therapyPotent topical activityAdministration of low doses directly at site of actionConsiderable efficacy at low dosesHigh topical:systemic activity ratiosRapid first-pass hepatic metabolism of any systemically absorbed drug,to compounds with negligible activityIntranasal corticosteroidsIndications:Moderate-severe intermittent or persistentor complicated with asthmaAdvantage:anti-inflammation effect is significantly superior to antihistaines safe,no systemic side effect Anti-leukotrieneAnti-leukotriene should be given for patients with bronchial symptoms or severe nasal symptomsActions of Various Nasal Preparations in the Treatment of RhinitisNasal PreparationSneezingItchingRhinorrhoeaCongestionAntihistamines+0Anticholinergics00+0Corticosteroids+Nasal PreparationSneezingItchingRhinorrhoeaCongestionDecongestants00+Mast cell stabiliser+0Antileukotrienes+0+Specific Immunotherapy(SIT)SIT is the practice of administering gradually increasing quantities of an allergen extract to an allergic subject to ameliorate symptoms associated with the subsequent exposure to the causative allergen.Specific immunotherapy needs a precise diagnosis of IgE-mediated allergy.Only measure to alter natual process of allergic rhinitis so farSpecial immunotherapyAllergen-specific immunotherapy was traditionally administered by the subcutaneous route but local routes are now available.Subcutaneous immunotherapy is effective in adults and children for pollen and mite allergy,but it is burdened by the risks of side effects.These reactions may be life-threatening.Sublingual immunotherapy is recommended for the treatment of pollen or mite allergy in adults.Special immunotherapyIndication:Early use to protect from development of bronchial complication(ARIA 2008)Hypersensitive to Dust mited or pollenAge:6 Contraindication:severe lung dysfunctionother immunologic diseasesBeta-blocker being usedpregnancy Step by step for AR treatment
    展开阅读全文
    提示  咨信网温馨提示:
    1、咨信平台为文档C2C交易模式,即用户上传的文档直接被用户下载,收益归上传人(含作者)所有;本站仅是提供信息存储空间和展示预览,仅对用户上传内容的表现方式做保护处理,对上载内容不做任何修改或编辑。所展示的作品文档包括内容和图片全部来源于网络用户和作者上传投稿,我们不确定上传用户享有完全著作权,根据《信息网络传播权保护条例》,如果侵犯了您的版权、权益或隐私,请联系我们,核实后会尽快下架及时删除,并可随时和客服了解处理情况,尊重保护知识产权我们共同努力。
    2、文档的总页数、文档格式和文档大小以系统显示为准(内容中显示的页数不一定正确),网站客服只以系统显示的页数、文件格式、文档大小作为仲裁依据,个别因单元格分列造成显示页码不一将协商解决,平台无法对文档的真实性、完整性、权威性、准确性、专业性及其观点立场做任何保证或承诺,下载前须认真查看,确认无误后再购买,务必慎重购买;若有违法违纪将进行移交司法处理,若涉侵权平台将进行基本处罚并下架。
    3、本站所有内容均由用户上传,付费前请自行鉴别,如您付费,意味着您已接受本站规则且自行承担风险,本站不进行额外附加服务,虚拟产品一经售出概不退款(未进行购买下载可退充值款),文档一经付费(服务费)、不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
    4、如你看到网页展示的文档有www.zixin.com.cn水印,是因预览和防盗链等技术需要对页面进行转换压缩成图而已,我们并不对上传的文档进行任何编辑或修改,文档下载后都不会有水印标识(原文档上传前个别存留的除外),下载后原文更清晰;试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓;PPT和DOC文档可被视为“模板”,允许上传人保留章节、目录结构的情况下删减部份的内容;PDF文档不管是原文档转换或图片扫描而得,本站不作要求视为允许,下载前可先查看【教您几个在下载文档中可以更好的避免被坑】。
    5、本文档所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用;网站提供的党政主题相关内容(国旗、国徽、党徽--等)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。
    6、文档遇到问题,请及时联系平台进行协调解决,联系【微信客服】、【QQ客服】,若有其他问题请点击或扫码反馈【服务填表】;文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“【版权申诉】”,意见反馈和侵权处理邮箱:1219186828@qq.com;也可以拔打客服电话:0574-28810668;投诉电话:18658249818。

    开通VIP折扣优惠下载文档

    自信AI创作助手
    关于本文
    本文标题:14高反应性鼻炎医学PPT课件.ppt
    链接地址:https://www.zixin.com.cn/doc/2566067.html
    页脚通栏广告

    Copyright ©2010-2026   All Rights Reserved  宁波自信网络信息技术有限公司 版权所有   |  客服电话:0574-28810668    微信客服:咨信网客服    投诉电话:18658249818   

    违法和不良信息举报邮箱:help@zixin.com.cn    文档合作和网站合作邮箱:fuwu@zixin.com.cn    意见反馈和侵权处理邮箱:1219186828@qq.com   | 证照中心

    12321jubao.png12321网络举报中心 电话:010-12321  jubao.png中国互联网举报中心 电话:12377   gongan.png浙公网安备33021202000488号  icp.png浙ICP备2021020529号-1 浙B2-20240490   


    关注我们 :微信公众号  抖音  微博  LOFTER               

    自信网络  |  ZixinNetwork